Publication | Closed Access

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

Metabolic SyndromeCombination Lipid-modifying TherapyLipid DisorderCardiovascular DiseasePractical GuidanceHyperlipidemiaDyslipidemiaLipoprotein MetabolismVery-high-risk PatientsPublic HealthMedicineAtherosclerosisEpidemiology